儿科代谢和腹部外科医生可用性的区域差异:呼吁采取行动
Norah E Liang1, Numa P Perez1, Vibha Singhal2
1Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
The Journal of surgical research
|December 12, 2023
概括
儿童肥胖是一个主要的健康问题. 由于进入障碍,代谢和减肥手术 (MBS) 在儿童中未得到充分使用,肥胖患病率和MBS提供者在各州之间存在显著的负相关性.
科学领域:
- 儿科公共卫生 儿科公共卫生
- 外科手术的准入.
- 肥胖医学 肥胖医学
背景情况:
- 儿童肥胖症是一个重大的公共卫生挑战.
- 代谢和减肥手术 (MBS) 建议用于严重的儿科肥胖症,但仍未得到充分利用.
- 对MBS的有限获取是导致儿童使用不足的一个关键因素.
研究的目的:
- 描述不同州儿童肥胖的流行情况.
- 为了比较特定州的儿科肥胖率与儿科代谢和减肥手术 (MBS) 提供者的可用性.
- 评估儿童肥胖患病率与获得手术护理之间的相关性.
主要方法:
- 利用国家特定的儿童肥胖率数据 (10-17岁) 来自国家儿童健康调查.
- 使用美国代谢和腹部外科医生协会会员目录识别了儿科MBS提供者.
- 计算了按州的MBS提供商的流行率,以作为访问的代理.
主要成果:
- 确定了儿童肥胖患病率和MBS提供者的可用性在各州之间存在显著的差异.
- 在肯塔基州,密西西比州,路易斯安那州,西弗吉尼亚州和阿拉巴马州,儿童肥胖率最高.
- 在儿童MBS提供者流行率低和儿童肥胖率高的国家之间发现了显著的负相关性 (r = -0.40,P = 0.002).
结论:
- 儿童肥胖的流行率和获得MBS的地理差异很大.
- 严重肥胖儿童MBS使用不足与提供者分配不平等有关.
- 开发可访问的,多学科的儿科减肥中心对于改善手术护理的准入至关重要.
相关概念视频
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...